Plasminogen activator inhibitor-1 and transforming growth factor-β1 in carotid glomus and autonomic ganglia from spontaneously hypertensive rats

Journal of Hypertension

Volumn 22, Issue 7, 2004, Pages 1351-1359

  Milei, José ^a   Cao, Gabriel ^b   Grana, Daniel R ^a   Toblli, Jorge E ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL ALEMÁN   (Argentina)

Author keywords

Carotid glomus; Hypertension; Plasminogen activator inhibitor 1; Spontaneously hypertensive rats; Transforming growth factor 1

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN S 100; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC GANGLION; CAROTID BODY; CONTROLLED STUDY; CORRELATION ANALYSIS; ESSENTIAL HYPERTENSION; EXTRACELLULAR MATRIX; FIBROSIS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SYSTOLIC BLOOD PRESSURE;

EID: 3042747929     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000125434.28861.9b     Document Type: Article

References (39)

1. Timmers HJLM, Karemaker JM, Wieling W, Marres HAM, Folgering HTM, Lenders JWM. Baroreflex and chemoreflex function after bilateral carotid body tumor resection. J Hypertens 2003; 21:591-599.
2. Holton P, Wood JB. The effects of bilateral removal of the carotid bodies and degeneration of the carotid sinuses in two human subjects. J Physiol (Lond) 1965; 181:365-378.
3. Robertson D, Hollister AS, Biaggioini I, Netterville JL, Mosqueda-Garcia R, Robertson RM. The diagnosis and treatment of the baroreflex failure. N Engl J Med 1993; 329:1449-1455.
4. Capps RB, de Takats G. The late effects of bilateral carotid sinus denervation in man. J Clin Invest 1938; 17:385-389.
5. Smiley RH, Campbell GS, Thompson WM, Haddy FJ. Successful treatment of a fulminant hypertensive crisis after bilateral carotid sinus denervation. Am J Surg 1967; 114:784-787.
6. Smit AAJ, Timmers HLJM, Wieling W, Wagenaar M, Marres HAM, Lenders JWM, et al. Long-term effects of carotid sinus denervation on arterial blood pressure in humans. Circulation 2002; 105:1329-1335.
7. Milei J, Lavezzi AM, Grana DR, Silvestri F, Bussari R, Rossi L, Matturri L. Severe carotid barochemoreceptor involvement in stroke. J Hypertens 2003; 21(suppl 4):S198.
8. Glenner GG, Grimley PM. Branchiomeric and intravagal paraganglia. In: Atlas of tumor pathology. 2nd series, fascicle 9. Tumors of the extraadrenal paraganglion system (including chemoreceptors). Washington DC: Armed Forces Institute of Pathology; 1974, pp. 17-33.
9. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88:1067-1072.
10. MacKenna D, Summerour SR, Villarreal FJ. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 2000; 46:257-263.
11. Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int 2000; 58:251-259.
12. Diamantopoulos EJ, Andreadis EA, Vassilopoulos CV, Theodorides TG, Giannakopoulos NS, Chatzis NA, Christopoulou-Kokkinou VD. Increased plasma plasminogen activator inhibitor-1 levels: a possible marker of hypertensive target organ damage. Clin Exp Hypertens 2003; 25:1-9.
13. Dahly AJ, Hoagland KM, Flasch AK, Jha S, Ledbetter SR, Roman RJ. Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats. Am J Physiol 2002; 283:R757-R767.
14. Williams B. Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol 2001; 87:10C-17C.
15. Kaplan A, Jack R, Opheim KE, Toivola B, Lyon AW (editors). Clinical chemistry. Interpretation and techniques. 4th ed. Philadelphia: Williams and Wilkins; 1995, pp. 220-250.
16. Kondo H, Iwanaga T, Nakajima T. Immunocytochemical study on the localisation of neuron-specific enolase and S-100 protein in the carotid body of rats. Cell Tissue Res 1982; 227:291-295.
17. Achilles E, Padberg BC, Holl K, Kloppel G, Schroder S. Immunocytochemistry of paragangliomas - value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology 1991; 18:453-458.
18. Janzer RC, Schneider J. The influence of chronically hypoxemic states on human carotid body structure and cardiac hypertrophy. Virchows Arch A Path Anat Histol 1977; 376:75-87.
19. Wei JY, Mendelowitz D, Anastasi N, Rowe JW. Maintenance of carotid baroreflex function in advanced age in the rat. Am J Physiol 1986; 250:R1047-R1051.
20. Cox RH, Bagshaw RJ, Detweiler DK. Arterial baroreceptor reflexes in young and old racing greyhounds. Am J Physiol 1981; 240:H383-H390.
21. McGarry K, Laher M, Fitzgerald D, Horgan J, O'Brien E, O'Malley K. Baroreflex function in elderly hypertensives. Hypertension 1983; 5:763-766.
22. Vlachakis ND, Mendlowitz M, Degusman D. Diminished baroreceptor sensitivity in elderly hypertensives: possible role of atherosclerosis. Atherosclerosis 1976; 24:243-249.
23. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83:1849-1865.
24. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000; 101:1130-1137.
25. Rocha R, Chander PN, Zuckerman A, Stier CT Jr. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 1999; 33:232-237.
26. Lam SY, Leung PS. A locally generated angiotensin system in rat carotid body. Regul Pept 2002; 107:97-103.
27. Rosenthal JH, Pfeifle B, Michailov ML, Pschorr J, Jacob IC, Dahlheim H. Investigations of components of the renin-angiotensin system in rat vascular tissue. Hypertension 1984; 6:383-390.
28. Kitami Y, Okura T, Wakamiya R, Marumoto K, Iwata T, Hiwada K. Regulation of the gene expression of type-1 angiotensin II receptor in spontaneously hypertensive rats. Blood Press 1992; 3(suppl):12-16.
29. Harrap SB. Angiotensin converting enzyme inhibitors, regional vascular hemodynamics, and the development and prevention of experimental genetic hypertension. Am J Hypertens 1991; 4:2123-2163.
30. Mizuno K, Tani M, Niimura S, Yamaguchi M, Inagami T, Fukuchi S. The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat. Am J Hypertens 1991; 4:603-663.
31. Dzau VJ, Ingelfinger JR. Molecular biology and pathophysiology of the intrarenal renin-angiotensin system. J Hypertens 1989; 7(suppl 7): S3-S8.
32. Wang Y, Hand AR, Wang YH, Mina M, Gillies C, Peng T, et al. Functional and morphologic evidence of the presence of tissue-plasminogen activator in vascular nerves: implications for a neurologic control of vessel wall fibrinolysis and rigidity. J Neurosci Res 1998; 53:443-453.
33. Hagedorn L, Floris J, Suter U, Sommer L. Autonomic neurogenesis and apoptosis are alternative fates of progenitor cell communities induced by TGFbeta. Dev Biol 2000; 228:57-72.
34. Schuster N, Bender H, Philippi A, Subramaniam S, Strelau J, Wang Z, Krieglstein K. TGF-beta induces cell death in the oligodendroglial cell line OLI-neu. Glia 2002; 40:95-108.
35. Klempt ND, Sirimanne E, Gunn AJ, Klempt M, Singh K, Williams C, Gluckman PD. Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res 1992; 13:93-101.
36. Docherty NG, Perez-Barriocanal F, Balboa NE, Lopez-Novoa JM. Transforming growth factor-beta1: a potential recovery signal in the post-ischemic kidney. Ren Fail 2002; 24:391-406.
37. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardio. 2001; 33:1191-1207.
38. Kaikita K, Schoenhard JA, Painter CA, Ripley RT, Brown NJ, Fogo AB, Vaughan DE. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. J Mol Cell Cardiol 2002; 34:617-627.
39. Amenta F, Strocchi P, Sabbatini M. Vascular and neuronal hypertensive brain damage: protective effect of treatment with nicardipine. J Hypertens Suppl 1996; 14:S29-S35.